Yazar "Turgut, Mehmet" için listeleme
-
Analysis of Elderly Patients with Chronic Myeloid Leukemia
Kelkitli, Engin; Goker, Hakan; Turgut, Mehmet; Atay, Memis Hilmi (Amer Soc Hematology, 2018)… -
Antiepileptic Effects of Melatonin
Seyithanoglu, M. Hakan; Turgut, Mehmet; Papaker, Meliha Gundag; Ayyildiz, Mustafa; Kaplan, Süleyman; Tuzgen, Saffet (Crc Press-Taylor & Francis Group, 2015)… -
Böbrek yetmezliği gelişen multipl miyelom tanılı hastalarda tedaviyle böbrek yetmezliğinin düzelmesine etkili faktörlerin incelenmesi
Soylu, Ahmet Faruk (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, 2022)Amaç: Çalışmamızda Multiple Miyelom (MM) tanılı ve akut böbrek yetmezliği (ABY) ile başvuran hastalarda böbrek yetmezliğinin prognozla ilişkisi, böbrek yetmezliğinin geri döndürülebilirliğine etkili faktörler ve hastaların ... -
Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors
Serefhanoglu, Songul; Goker, Hakan; Buyukasik, Yahya; Turgut, Mehmet; Sayinalp, Nilgun; Haznedaroglu, Ibrahim Celalettin; Ozcebe, Osman Ilhami (Springer, 2009)The roles of vascular endothelial growth factor (VEGF), Tie-2, and angiopoietins in the mobilization of the hematopoietic stem cells (HSCs) in humans are not yet clearly understood. In order to elucidate mechanisms of HSC ... -
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience
Goker, Hakan; Ozdemir, Evren; Uz, Burak; Buyukasik, Yahya; Turgut, Mehmet; Serefhanoglu, Songul; Ozcebe, Osman I. (Pergamon-Elsevier Science Ltd, 2013)Due to the high transplant related morbidity and mortality (TRM), relatively younger acute leukemia patients that have a good performance status and no comorbidity are eligible for myeloablative conditioning (MAC) followed ... -
Effect of LIM domain only (LMO2) protein expression on survival in multiple myeloma patients.
Kelkitli, Engin; Atay, Memis Hilmi; Yildiz, Levent; Turgut, Mehmet (Amer Soc Clinical Oncology, 2013)… -
Effect of pinealectomy on the morphology of the chick cervical spinal cord: A stereological and histopathological study
Turgut, Mehmet; Tunc, Ayten Turkkani; Aslan, Huseyin; Yazici, Ayse Canan; Kaplan, Süleyman (Elsevier Science Bv, 2007)Melatonin has some effects upon morphological features of various structures in small animals and human being. in this study, the changes induced by pinealectomy procedure on morphological features of developing cervical ... -
Effects of Ca2+channel blocker verapamil on tissue regeneration in a lizard tail autotomy model: a biochemical and histological study
Turgut, Mehmet; Koca, Yucel B.; Kaplan, Süleyman; Metin, Kubilay; Uzum, Nazan; Soylu, Emrah; Olgun, Kurtulus (Brill Academic Publishers, 2007)Ca2+ ions have been reported to augment the activities of many cell types including cellular proliferation and tissue regeneration. Moreover, it is well known that verapamil is a L-type voltage-gated Ca2+ antagonist with ... -
Effects of Melatonin on Osteoblastic and Osteoclastic Activities of Bone Tissue
Papaker, Meliha Gundag; Seyithanoglu, M. Hakan; Turgut, Mehmet; Kaplan, Süleyman; Tuzgen, Saffet (Crc Press-Taylor & Francis Group, 2015)… -
Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey
Turgut, Mehmet; Soyer, Nur; Ali, Rıdvan; Haznedaroğlu, İbrahim; Yılmaz, Fergun; İlhan, Gül; Cömert, Melda; Aslaner, Müzeyyen; İnce, İdris; Yavaşoğlu, İrfan; Özdemirkıran, Füsun; Özet, Gülsüm; Vural, Filiz; Şahin, Fahri; Töbü, Mahmut; Onmuş, İsabel Raika Durusoy; Saydam, Güray (TÜBİTAK, 2021)The aim of this study is to assess the efficacy and safety of ruxolitinib in patients with myelofibrosis. Materials and methods: From 15 centers, 176 patients (53.4% male, 46.6% female) were retrospectively evaluated. ... -
EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate
Uz, Burak; Buyukasik, Yahya; Atay, Hilmi; Kelkitli, Engin; Turgut, Mehmet; Bektas, Ozlen; Haznedaroglu, Ibrahim C. (Taylor & Francis Ltd, 2013)Objectives: The validity of the three currently used chronic myeloid leukemia (CML) scoring systems (Sokal CML prognostic scoring system, Euro/Hasford CML scoring system, and the EUTOS CML prognostic scoring system) were ... -
Havayolunu Tikayan Izole Dil Kökü Yerleşimli Lenfoma
Ekstranodal lenfomalar gastrointestinal sistemden sonra en sık baş boyun bölgesinde, Waldeyer lenfatik halkasında yerleşimgösterirler.Dilkökündekiyerleşimi ise oldukça nadirdir. 39 yaşında mobilya işçisi erkek hasta birkaç ... -
Impact of Fluorescent in Situ Hybridization Aberrations and CLLU1 Expression on the Prognosis of Chronic Lymphocytic Leukemia: Presentation of 156 Patients from Turkey
Abur, Ummet; Ogur, Gonul; Akar, Omer Salih; Altundag, Engin; Aymelek, Huri Sema; Ozatli, Duzgun; Turgut, Mehmet (Galenos Yayincilik, 2018)Objective: This study evaluates the impact of CLLU1 expression and fluorescent in situ hybridization (FISH) analysis of a group of Turkish chronic lymphocytic leukemia (CLL) patients. Materials and Methods: A total of 156 ... -
The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases
Aktimur, Sude H.; Malkan, Umit Y.; Eyupoglu, Damla N.; Haznedaroglu, Ibrahim C.; Kelkitli, Engin; Atay, Hilmi M.; Turgut, Mehmet (Akad Doktorlar Yayinevi, 2016)Ruxolitinib as a JAK1 and JAK2 inhibitor drug has recently been approved for the treatment of patients with high-or intermediate-risk myelofibrosis with symptomatic splenomegaly. Clinical development of ruxolitinib has ...